"continuing medication" is a correct and usable phrase in written English.
It can be used when referring to the process of taking medication on a regular basis for an ongoing health issue. For example, "The doctor advised me to continue my medication until the condition has improved."
Our findings align with aspects of supplementary prescribing, i.e. that a pharmacist prescribes in accordance to a clinical management plan, by continuing medication that has been approved by the patient's medical prescriber [ 36].
Within the professions, opinions on continuing medication, lowering the dose or stepping down varied widely.
As the symptoms go unnoticed, young individuals may not pay much attention to the importance of continuing medication.
Discontinuation of medication use steadily increased thereafter for both drug and race groups, with fewer blacks continuing medication use than whites.
In these patients, the pharmacist was able, in most cases, to restart ULT and continue testing to assure continuing medication adherence.
Because mast cell degranulation has been observed hours after trigger application, we recommend continuing medication for at least 4 hours after trigger application.
Third, the medication reporting reflects physician's best knowledge of new or continuing medications, and thus these data do not provide insights into patients' adherence with therapy or other aspects of patients' medication-taking behaviors.
Once a month after the methylphenidate adaptation period, a doctor checked for any side effects that might impede continued medication and offered advice to alleviate poor appetite, sleep, or other problems in order to better adjust treatment.
We recommend that patients continue with some type of therapy after completing a detox program and continue medication maintenance for opioid use disorder.
This patient had a myxoid liposarcoma and continued medication for 6 months before progression was noted.
The primary reasons for discontinuation were AEs (linagliptin, 11.8; placebo, 16.9%) and refusal to continue medication (linagliptin, 10.3; placebo, 1.5%).
